Amiotrófiás laterálszklerózis (ALS): vizsgálatok itt: Ukrajna
1 trial · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleEfficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- Where
- Kharkiv, Kyiv, Lviv
- Életkor
- 18 év to 81 év
- People
- 495 worldwide
- Run by
- AB Science
See details and how to joinNCT03127267